XNYS · Healthcare · Medical Distribution
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Q3 2026 | 2.80 | 3.17 | +13.21% | $60.94B | ✅ Beat | +0.09% | -3.94% | +2.03% |
| 2026-02-05 | Q2 2026 | 2.37 | 2.63 | +10.97% | $65.63B | ✅ Beat | +4.18% | -5.33% | -4.14% |
| 2025-10-30 |
| Q1 2026 |
| 2.19 |
| 2.55 |
| +16.44% |
| $64.01B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-12 | Q4 2025 | 2.03 | 2.08 | +2.46% | $60.16B | ✅ Beat | — | — | — |
| 2025-05-01 | Q3 2025 | 2.17 | 2.35 | +8.29% | $54.88B | ✅ Beat | +2.75% | +1.20% | +6.68% |
| 2025-01-30 | Q2 2025 | 1.76 | 1.93 | +9.66% | $55.26B | ✅ Beat | -3.59% | -0.94% | +0.72% |
| 2024-11-01 | Q1 2025 | 1.62 | 1.88 | +16.05% | $52.28B | ✅ Beat | -3.64% | +3.81% | +5.46% |
| 2024-08-14 | Q4 2024 | 1.73 | 1.84 | +6.36% | $59.87B | ✅ Beat | +1.46% | +3.09% | +6.40% |
Showing last 8 quarters.